Evidence for an active site arginine in UDP-glucuronyltransferase

• Published in: The Journal of biological chemistry 1983-05, Vol.258 (10), p.6430-6434
• Main Authors: Zakim, D, Hochman, Y, Kenney, W C
• Format: Article
• Language: English
• Subjects: Amino Acids - analysis; Animals; Arginine; Binding Sites - drug effects; Butanones - pharmacology; Diacetyl - pharmacology; Glucuronates - pharmacology; Glucuronic Acid; Glucuronosyltransferase - analysis; Glucuronosyltransferase - antagonists & inhibitors; Kinetics; Microsomes, Liver - enzymology; Swine; Uridine Diphosphate - pharmacology; Uridine Diphosphate Glucuronic Acid - pharmacology
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(18)32428-1

2,3-Butanedione inactivates the pure form of UDP-glucuronyltransferase used in these experiments (GT2P) (EC 2.4.1.17) purified from pig liver microsomes. The kinetics of the reaction indicates that 2,3-butanedione reacts with two amino acids that affect activity. A rapid, partial inactivation is followed by a slower rate of inactivation that leads eventually to completely inactive enzyme. UDP-glucuronic acid and glucuronic acid, as compared with UDP, are effective as protectors against the slow, secondary phase of inactivation; no ligand tested protected against the rapid phase of inactivation. The lipid environment of GT2P was a determinant of the pseudo-first order rate constant for the slow phase of inactivation, but did not affect the rate of the rapid phase of inactivation. The data suggest that GT2P contains an active site arginine that interacts with the -COO- at C-6 of the glucuronic acid moiety of UDP-glucuronic acid.